Researchers at the Massachusetts Institute of Technology are taking 3D printing one step further. Their findings, recently published in Advanced Materials, indicate that the methods used for traditional 3D printing can also be used to print living materials; they were able to integrate programmable bacteria into their 3D printing ink.
In the world of health tech, 3D printing may not get as much buzz as robotics or machine learning. But that’s something 3DHeals wants to change. Its first-ever Boston event on Aug. 3 focused on 3D printing and its challenges and opportunities for healthcare.
But this isn’t the first time the hospital’s SIMPeds program has pioneered patient simulation–and likely won’t be the last.
The low-cost, open-sourced design rides wave of prosthetics “revolution”
Last month, the FDA approved manufacture of the world’s first 3D printed pill Spritam, an anti-epileptic seizure drug. We caught up with Michael Cima, one of the inventors of 3D printing and a professor at MIT, to find out what this development means for the future of the pharmaceutical industry.